Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05694286 · ClinicalTrials.gov registry record · NA
A Prospective Evaluation of Infraorbital Filler Injection
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05694286: Completed NA study, sponsored by University of Pennsylvania.
NCT05694286 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05694286, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.
Interventions
- PROCEDURE Juvederm Volbella XC hyaluronic acid dermal filler injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2023-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05694286
The ClinicalTrials.gov registry entry for NCT05694286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Juvederm Volbella XC hyaluronic acid dermal filler injection is the first listed.
NCT05694286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05694286 about?
NCT05694286 is a clinical study titled "A Prospective Evaluation of Infraorbital Filler Injection". The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photo...
What is the current status of trial NCT05694286?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-01-06. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT05694286?
The interventions under investigation include: Juvederm Volbella XC hyaluronic acid dermal filler injection (PROCEDURE).
Who is sponsoring clinical trial NCT05694286?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.